GlassScriptPhysician profile
Samuel Kaufman
NPI 1912993601
$12,059.77
in general payments reported to CMS, 2019-2025
29 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $340 · 2021: $462 · 2022: $111 · 2023: $10K · 2024: $66.89 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,075 · Travel and Lodging: $887 · Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,075.00 |
| Travel and Lodging | $887.03 |
| Food and Beverage | $806.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $10,649.98 | 2019-2025 | |
| Myovant Sciences INC. | $176.11 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.29 | 2021-2025 | |
| Therapeuticsmd, INC. | $128.83 | 2019-2020 | |
| Medicem INC. | $99.73 | 2021 | |
| Allergan, INC. | $97.90 | 2019-2020 | |
| Coopersurgical, INC. | $86.89 | 2021-2024 | Paragard T 380a |
| Astellas Pharma US INC | $75.33 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $65.89 | 2021-2025 | Aptima, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Millicent US INC | $63.87 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Otsuka America Pharmaceutical, INC. | $57.90 | 2025 | Rexulti |
| Pfizer INC. | $45.03 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $40.04 | 2023 | |
| Duchesnay USA Incorporated | $39.29 | 2019 | |
| Lilly USA, LLC | $36.46 | 2023 | Jardiance |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $32.84 | 2025 | Cologuard Collection Kit |
| Lupin INC. | $25.71 | 2019-2021 | |
| Avion Pharmaceuticals | $24.70 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $19.47 | 2021 | |
| Amag Pharmaceuticals, INC. | $18.11 | 2019 | |
| Exeltis, USA INC. | $17.83 | 2019 | |
| Agile Therapeutics, INC. | $17.81 | 2021 | |
| Amgen INC. | $14.61 | 2019 | |
| Sumitomo Pharma America, INC. | $14.34 | 2023 | Myfembree |
| Glaxosmithkline, LLC. | $14.10 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.38 | 2020 | |
| Roche Diagnostics Corporation | $13.04 | 2019 | |
| Novo Nordisk INC | $12.99 | 2023 | Wegovy |
| Avanos Medical | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.